These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

330 related items for PubMed ID: 12009017

  • 1. Differential activation of cysteine-substitution mutants of fibroblast growth factor receptor 3 is determined by cysteine localization.
    Adar R, Monsonego-Ornan E, David P, Yayon A.
    J Bone Miner Res; 2002 May; 17(5):860-8. PubMed ID: 12009017
    [Abstract] [Full Text] [Related]

  • 2. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia.
    Naski MC, Wang Q, Xu J, Ornitz DM.
    Nat Genet; 1996 Jun; 13(2):233-7. PubMed ID: 8640234
    [Abstract] [Full Text] [Related]

  • 3. Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations.
    Ronchetti D, Greco A, Compasso S, Colombo G, Dell'Era P, Otsuki T, Lombardi L, Neri A.
    Oncogene; 2001 Jun 14; 20(27):3553-62. PubMed ID: 11429702
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Constitutive activation of fibroblast growth factor receptor 3 by mutations responsible for the lethal skeletal dysplasia thanatophoric dysplasia type I.
    d'Avis PY, Robertson SC, Meyer AN, Bardwell WM, Webster MK, Donoghue DJ.
    Cell Growth Differ; 1998 Jan 14; 9(1):71-8. PubMed ID: 9438390
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Reduced binding of FGF1 to mutant fibroblast growth factor receptor 3.
    Khnykin D, Olsnes S.
    Growth Factors; 2006 Jun 14; 24(2):111-9. PubMed ID: 16801131
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells.
    Nowroozi N, Raffioni S, Wang T, Apostol BL, Bradshaw RA, Thompson LM.
    Hum Mol Genet; 2005 Jun 01; 14(11):1529-38. PubMed ID: 15843401
    [Abstract] [Full Text] [Related]

  • 14. Insulin-like growth factor-1 rescues the mutated FGF receptor 3 (G380R) expressing ATDC5 cells from apoptosis through phosphatidylinositol 3-kinase and MAPK.
    Koike M, Yamanaka Y, Inoue M, Tanaka H, Nishimura R, Seino Y.
    J Bone Miner Res; 2003 Nov 01; 18(11):2043-51. PubMed ID: 14606518
    [Abstract] [Full Text] [Related]

  • 15. K644E/M FGFR3 mutants activate Erk1/2 from the endoplasmic reticulum through FRS2 alpha and PLC gamma-independent pathways.
    Lievens PM, Roncador A, Liboi E.
    J Mol Biol; 2006 Mar 31; 357(3):783-92. PubMed ID: 16476447
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Parathyroid hormone receptor type 1/Indian hedgehog expression is preserved in the growth plate of human fetuses affected with fibroblast growth factor receptor type 3 activating mutations.
    Cormier S, Delezoide AL, Benoist-Lasselin C, Legeai-Mallet L, Bonaventure J, Silve C.
    Am J Pathol; 2002 Oct 31; 161(4):1325-35. PubMed ID: 12368206
    [Abstract] [Full Text] [Related]

  • 19. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1).
    Rousseau F, el Ghouzzi V, Delezoide AL, Legeai-Mallet L, Le Merrer M, Munnich A, Bonaventure J.
    Hum Mol Genet; 1996 Apr 31; 5(4):509-12. PubMed ID: 8845844
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.